🗞️ In @CCR_AACR, the 1st #IMMUNOMICSVHIO study co-led by R. Toledo & E. Garralda shows that ultrasensitive liquid biopsy can predict and monitor immunotherapy response in advanced cancers, helping identify responders earlier and guide treatment decisions.

➡️ linke.to/IMMUNOMIX_eng

#CAIMI #UITM